Sub-cellular localization of vesicular stomatitis virus messenger RNAs.

Membrane assembly in vitro: synthesis, glycosylation, and asymmetric insertion of a transmembrane protein. Proc Natl Acad Sci U S A (1977) 5.51

Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus. J Virol (1977) 4.03

Localization of two cellular forms of the vesicular stomatitis viral glycoprotein. J Virol (1977) 3.20

5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73

Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells. J Virol (1975) 2.68

Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 2.29

Glycosylation of vesicular stomatitis virus glycoprotein in virus-infected HeLa cells. J Virol (1976) 2.06

The M protein of vesicular stomatitis virus associates specifically with the basolateral membranes of polarized epithelial cells independently of the G protein. J Cell Biol (1988) 1.75

Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A (1979) 1.66

Association of vesicular stomatitis virus proteins with HeLa cell membranes and released virus. J Virol (1976) 1.57

Intracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells. J Virol (1985) 1.56

Vesicular stomatitis virus glycoprotein is anchored to intracellular membranes near its carboxyl end and is proteolytically cleaved at its amino terminus. J Virol (1979) 1.47

Membrane-bound ribosomes of myeloma cells. IV. mRNA complexity of free and membrane-bound polysomes. J Cell Biol (1981) 1.33

Assembly of viral membranes: nature of the association of vesicular stomatitis virus proteins to membranes. J Virol (1978) 1.17

Assembly of viral membranes: maturation of the vesicular stomatitis virus glycoprotein in the presence of tunicamycin. J Virol (1978) 1.02

Transfer of carbohydrates on to nascent glycoprotein of vesicular stomatitis virus. Biochem J (1979) 0.93

Studies on the mechanism for entry of vesicular stomatitis virus glycoprotein G mRNA into membrane-bound polyribosome complexes. J Cell Biol (1977) 0.89

Binding of viral glycoprotein mRNA to endoplasmic reticulum membranes is disrupted by puromycin. J Cell Biol (1977) 0.88

5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev (1980) 6.14

Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 5.88

Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science (1981) 5.66

Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02

Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ (1997) 4.95

The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43

Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17

Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05

A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82

Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash. Virology (1979) 3.61

Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology (1994) 3.52

Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA (1997) 3.47

Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol (1997) 3.40

Oxygen desaturation during endoscopy in the elderly. J R Coll Physicians Lond (1993) 3.37

Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol (1988) 3.28

In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 3.17

Transcription in vitro by reovirus-associated ribonucleic acid-dependent polymerase. J Virol (1970) 3.07

Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06

Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04

Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A (1971) 2.99

Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology (1974) 2.83

Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry. Proc Natl Acad Sci U S A (1996) 2.82

Isolation of a viral polypeptide associated with poliovirus RNA polymerase. Proc Natl Acad Sci U S A (1974) 2.79

5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73

Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73

Translation and identification of the viral mRNA species isolated from subcellular fractions of vesicular stomatitis virus-infected cells. J Virol (1975) 2.68

Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol (1985) 2.65

Translation of poliovirus RNA in vitro: detection of two different initiation sites. J Mol Biol (1975) 2.58

Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci U S A (1986) 2.45

In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42

Unique mode of transcription in vitro by Vesicular stomatitis virus. Cell (1980) 2.36

Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus. Nature (1975) 2.36

Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. Virology (1993) 2.33

Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J Virol (1988) 2.32

Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors. J Virol (1978) 2.31

An internal 5'-noncoding region required for translation of poliovirus RNA in vitro. J Virol (1988) 2.29

An infectious clone of human parainfluenza virus type 3. J Virol (1997) 2.28

Soluble RNA polymerase complex from poliovirus-infected HeLa cells. Virology (1970) 2.26

Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys (1996) 2.15

Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15

Formation of the poliovirus replication complex requires coupled viral translation, vesicle production, and viral RNA synthesis. J Virol (2000) 2.13

Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol (1997) 2.13

Viral proteins required for the in vitro replication of vesicular stomatitis virus defective interfering particle genome RNA. Virology (1988) 2.11

Assembly of vesicular stomatitis virus glycoprotein and matrix protein into HeLa cell plasma membranes. J Mol Biol (1976) 2.10

Phosphorylation of vesicular stomatitis virus in vivo and in vitro. J Virol (1974) 2.07

Adenylate-rich sequences in vesicular stomatitis virus messenger ribonucleic acid. J Virol (1972) 2.05

Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc Natl Acad Sci U S A (1992) 2.03

Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02

Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA (1999) 2.00

Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99

Initiation and replication of vesicular stomatitis virus genome RNA in a cell-free system. Proc Natl Acad Sci U S A (1983) 1.95

Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. Cell (1987) 1.92

Untranslated vesicular stomatitis virus messenger RNA after poliovirus infection. Virology (1977) 1.92

Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92

Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol (1988) 1.91

In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90

Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J Virol (1992) 1.88

Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J Virol (1984) 1.87

Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro. Proc Natl Acad Sci U S A (1986) 1.87

Th size and shape of bacteria by light scattering measurements. Biochim Biophys Acta (1968) 1.85

Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro. Biochem Biophys Res Commun (1985) 1.79

Poliovirus-induced inhibition of host-cell protein synthesis. Cell (1982) 1.79

Poliovirus RNA replication. Curr Top Microbiol Immunol (1990) 1.78

Parasitic infections of the lung: a guide for the respiratory physician. Thorax (2010) 1.78

Mapping and initiation studies on the leader RNA of vesicular stomatitis virus. Virology (1977) 1.78

Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77

Alterations in initiation factor activity from poliovirus-infected HeLa cells. J Biol Chem (1979) 1.75

Vesicular stomatitis virus NS proteins: structural similarity without extensive sequence homology. J Virol (1985) 1.73

Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase. J Virol (1993) 1.73

The cap-binding protein complex in uninfected and poliovirus-infected HeLa cells. J Biol Chem (1987) 1.73

Cytoplasm from poliovirus-infected HeLa cells inhibits cell-free haemoglobin synthesis. Nat New Biol (1971) 1.72

Genetic and physiological analysis of conjugation in Streptococcus faecalis. J Bacteriol (1982) 1.72

Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.63

The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol (1995) 1.61

Initiation of reovirus mRNA synthesis in vitro. Nat New Biol (1971) 1.61

Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity. J Virol (1991) 1.60

Simultaneous pulmonary and cerebral oedema, and multiple CNS infarctions as complications of diabetic ketoacidosis: a case report. Diabet Med (2006) 1.60

Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro. J Virol (1986) 1.60

The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus. Virology (1976) 1.60

Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58

Resolution of multiple complexes of phosphoprotein NS with nucleocapsid protein N of vesicular stomatitis virus. J Virol (1988) 1.57

The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol (1991) 1.55

Comparison of replication complexes synthesizing poliovirus RNA. Virology (1981) 1.55

Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM (2002) 1.54

In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs. J Virol (1985) 1.53

Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol (1994) 1.52

In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51

Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase. Virology (1983) 1.51

RNA duplex unwinding activity of poliovirus RNA-dependent RNA polymerase 3Dpol. J Virol (1993) 1.51

Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis. Ann Surg (1992) 1.51

Requirements for assembly of poliovirus replication complexes and negative-strand RNA synthesis. J Virol (2001) 1.50